https://www.selleckchem.com/products/tmp195.html
72 (CC1 95% CI = 0.51-1.03, P = 0.07) for PPI users and 0.95 (CC2 95% CI = 0.74-1.22, P = 0.69) for H2 antagonist users, when compared to non-users. Between the patients using acid suppressants, there was no difference between PPI and H2 antagonist users in the risk of developing dementia (CC3 aHR = 0.82, 95% CI = 0.58-1.17, P = 0.28). In conclusion, no association was observed between the use of acid suppressants and the risk of developing dementia in any of the three CCs. Further, randomized controlled trials are warranted to confirm t
Like
Comment
Share
